Community Opioid Intervention Prevention Program
ALERT ON TIANEPTINE
Tianeptine, a tricyclic antidepressant available overseas, has not been approved by the U.S. Food and Drug Administration for any medical use and is not legally available here.
Products containing tianeptine are illegally being sold and promoted in the U.S., often in health supplements with unproven health claims, and can lead to misuse, dependence, overdose, and death.
U.S. Poison control center cases of severe side effects involving tianeptine have and continue to increase, from 11 total cases between 2000 and 2013 to 151 cases in 2020.
Read and download the IHS Alert on Tianeptine flyer. [PDF 302 KB]
COIPP FY 2022-2023 Report
COIPP Results from Year Two Now Available
At the end of each program year, COIPP grantees submit annual data through progress report templates. The National Report includes information from all progress reports submitted for the program year and covers data on the activities each project is implementing in their respective areas.
- Year Two: Community Opioid Intervention Pilot Projects FY 2022-2023 Report [PDF 1.5 MB] (September 2022-September 2023)
- Read the year one report, Community Opioid Intervention Pilot Projects FY 2021-2022 Report [PDF 1.2 MB] (September 2021-September 2022)
Grants Awarded to Combat the Opioid Epidemic in Indian Country
The IHS Office of Clinical and Preventive Services, Division of Behavioral Health awarded 35 grants to Tribes, Tribal organizations, and Urban Indian organizations to combat the opioid epidemic in Indian Country. This expanded funding is part of the Department of Health and Human Services? five-point strategy to fight the opioid overdose epidemic in America.
The Community Opioid Intervention Pilot Projects (COIPP) grantees will implement innovative approaches to address the opioid crisis in American Indian/Alaska Native (AI/AN) communities through the following objectives:
- Increase public awareness and education about culturally-appropriate and family-centered opioid prevention, treatment, and recovery practices and programs.
- Create comprehensive support teams to strengthen and empower AI/AN families by addressing the opioid crisis.
- Reduce unmet treatment needs and opioid overdose related deaths through the use of medication assisted treatment (MAT).
Read the list of 2021 COIPP Grant awardees [PDF - 471 KB].
COIPP Application information is for reference only and may be found on the COIPP Funding Information page.
